RTS Life Science, a worldwide supplier of automated sample management and drug delivery testing systems, has partnered with Hall Analytical Laboratories to provide analytical services and consultancy in the area of automation and inhaler testing. Initially focussed on inhaled drug delivery devices, the two companies will share facilities, technology and resources to provide a range of services to help organisations improve efficiency in the development, adoption and use of automation.
Combining RTS Life Science's device testing expertise and automated inhaler testing technology with Hall Analytical Laboratories' analytical problem solving expertise and GxP accredited facilities, clients can be confident that their analytical and automation needs for inhaled product testing will be understood and approached with a refreshing new depth of insight. Services to be provided in consultation with clients include:
• Method development for both manual and automated applications;
• Equipment and analytical validation services;
• Performance qualification of automation systems;
• Laboratory and analytical consultancy for OINDP products;
• Canister content testing;
• Emitted and delivered dose uniformity testing.
Mark Fish, Director of Drug Delivery Automation for RTS Life Science commented, "Our experience of inhaler testing automation means we understand how devices work and appreciate factors that can introduce variability in analytical testing. In addition, we have proven experience validating automation systems in accordance with the latest regulatory guidance. By offering these services, customers will benefit from this knowledge and have new options to help improve laboratory efficiency."
Malcolm Kimber, Managing Director of Hall Analytical Laboratories commented, "Hall Analytical is focussed on our customers and understanding their needs. This partnership with RTS allows us to offer a more comprehensive range of services for inhaled devices, building on our experience working with pharmaceutical clients and our excellent reputation for regulatory compliance and analytical problem solving".
RTS Life Science is a leading provider of inhaler automation solutions with over 14 years' experience in the development of mechanical, physical and analytical testing systems for pressurised metered dose and dry powder inhaler devices. With a range of product solutions from fully automated to specialist semi automation in daily use in both pharmaceutical product development and quality control environments, RTS has a deep understanding of the specialised and challenging techniques associated with the testing of inhaled devices.
Hall Analytical Laboratories has over 25 years' experience providing problem solving analytical services for pharmaceutical applications. With GxP certified laboratory facilities, a comprehensive range of validated mass spectrometric and chromatographic instrumentation, and experienced scientists trained to the highest standards ensure clients have the utmost confidence in results. Hall Analytical works closely with clients to ensure their needs are fully understood, and offers both routine sample analysis and study or project based services.
About RTS Life Science
RTS Life Science (rtslifescience.com) is a UK-based supplier of drug discovery and drug delivery automation solutions for sample management and high throughput testing in laboratories. RTS Life Science is owned by Robotic Technology Systems PLC, an AIM-listed company.
For further press information please contact: Celine Callender, The Scott Partnership, 1, Whiteside, Station Road, Holmes Chapel, Cheshire, CW4 8AA United Kingdom T: +44 1477 539539 - F: +44 1477 539540 - E: rts[.]scottpr.com.